NCT05399940

Brief Summary

Purpose: To find the correlation between hemogram parameters and Delta Neutrophil Index(DNI) and Serum PSA in patients presenting with the diagnosis of acute prostatitis. Material-Metod: Serum PSA levels and hemogram parameters of patients who came to the urology outpatient clinic in January 2018 and May 2022 and were diagnosed with prostatitis were collected retrospectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2022

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 27, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 1, 2022

Completed
Last Updated

June 1, 2022

Status Verified

May 1, 2022

Enrollment Period

4.3 years

First QC Date

May 27, 2022

Last Update Submit

May 31, 2022

Conditions

Keywords

prostatit

Outcome Measures

Primary Outcomes (1)

  • Area Under the Plasma Concentration Versus Time Curve (AUC)

    4 years

Study Arms (2)

Group 1

:PSA\<4 ng/mL

Diagnostic Test: Serum PSA,Delta Neutrophil Index(DNI),WBC

Group 2

PSA\>4 ng/mL

Diagnostic Test: Serum PSA,Delta Neutrophil Index(DNI),WBC

Interventions

Urine culture, prostate volume

Also known as: MPV,NLR,RDW
Group 1Group 2

Eligibility Criteria

Age18 Years - 90 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult male patients with acute prostatitis were included in the study.

You may qualify if:

  • Acute prostatitis Male

You may not qualify if:

  • Prostate cancer Chronic prostatitis Other Urinary infections,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Basri Cakiroglu

Istanbul, 34768, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Prostatic DiseasesProstatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
4 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ass. Prof.

Study Record Dates

First Submitted

May 27, 2022

First Posted

June 1, 2022

Study Start

January 1, 2018

Primary Completion

May 1, 2022

Study Completion

May 20, 2022

Last Updated

June 1, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

re

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations